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Abstract
Background: Snuff or smokeless tobacco, used orally or by nasal application, is the predominant form of tobacco used by black 
South African women. Little is known about the risk of cardiovascular disease associated with the use of snuff in developing countries. 
This study therefore sought to determine the association between snuff use and hypertension among black South African women. 
Methods: This study involved secondary data analysis of a cross-sectional representative sample of black women aged 25 to 70 years 
(n = 4092) who participated in the 1998 South African Demographic and Health Survey, the largest to date. Data analysis included 
chi-square statistics, t-tests, ANOVA and multiple logistic regression analysis. The outcome measure was hypertension, defined as 
presenting with an average blood pressure (BP) of ≥ 160/95 mmHg, and/or reporting the use of antihypertensive medication. 
Results: The prevalence of snuff use and hypertension was 14.6% and 18.0% respectively. Compared to non-users of snuff, 
those who used snuff more than eight times a day had significantly higher mean systolic (131 mmHg vs. 121 mmHg) and diastolic 
(84 mmHg vs. 77 mmHg) BP. Hypertension was more prevalent among snuff users than among non-users of snuff (23.9% vs. 
17%; p<0.001). However, after adjusting for potential confounders, although current snuff use as compared to non-current use 
produced a dose response, it was not associated with a statistically significant increased risk for hypertension (OR = 1.12; 95% 
CI: 0.84-1.50). 
Conclusion: This study failed to show a significant association between snuff use and hypertension. However, heavy snuff use 
significantly increased BP to levels that have been shown to increase the risk for cardiovascular diseases at a population level. 
While there is need for follow-up studies, this finding of the study highlights the need for primary care physicians to offer tobacco 
use cessation services to their patients, especially those who may already be exposed to other risk factors for hypertension.
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Introduction 
Hypertension is a global health burden and a major risk factor for the 
development of cardiovascular diseases among all race groups.1,2,3 A 
number of factors, including tobacco use, have been associated with 
the development of hypertension among both South African men and 
women, irrespective of their race/ethnicy.2,3 However, the majority of 
black South African women who use tobacco products do so in the 
form of snuff, with a national prevalence estimated at 13.2% in 1998, 
compared to a smoking prevalence of 5.3% in the same population 
group.4 Whereas the health consequences of smoking are well 
documented, only limited information is available on the health effects 
of smokeless tobacco or snuff use.
Some studies have shown that the use of oral snuff or smokeless 
tobacco may predispose a person to higher systolic and diastolic 
blood pressures,5,6,7 and significantly increase the risk for myocardial 
infarction.8 A few studies have also suggested an acute elevation of 
blood pressure following snuff-dipping, ascribed to the mineralocorticoid 
activities of nicotine, the high sodium content and possibly the 
effect of liquorice additives.9,10,11 However, other studies have failed to 
confirm a significant association between the risk for hypertension or 
cardiovascular disease and the use of snuff.12,13 Nevertheless, a more 
recent large-scale study suggests that snuff may increase mortality 
from heart disease and stroke.14
Among black South Africans, hypertension is the single most important 
risk factor for cardiovascular disease.3 Most of the existing studies 
on the association of snuff with cardiovascular disease are derived 
mainly from the study of Caucasian male snuff-dippers in developed 
countries.5,9,10,11,12,13 Due to the lack of consistent associations between 
snuff and major diseases (particularly in developed nations), snuff 
is promoted as a reduced-harm product.15,16 Although snuff use in 
South Africa, which includes the nasal use of both moist and dry snuff, 
may be different from the pattern of use in developed nations,17,18 it 
is similarly perceived by some South African adolescents as a safer 
alternative to cigarettes.19
Given the inconsistencies in the findings of previous studies and 
the lack of evidence for an association between snuff use and 
hypertension in South Africa, this study sought to determine the 
association between the use of snuff and hypertension among black 
South African women.
Methods
Data source and study design
Data for this study were obtained from individuals aged 25 to 70 years 
old who participated in the 1998 South African Demographic and 
Health Survey (SADHS). The 1998 SADHS was the first and, to date, 
the largest publicly available SADHS dataset. The 1998 SADHS was a 
nationally representative, cross-sectional household survey conducted 
between February and September 1998. The 1998 SADHS used 
a stratified, two-staged probability sample design. Methods of data 
collection, interviews and consent have been published previously.4,20 
Black African women who participated in the 1998 SADHS and were 
between the ages of 25 and 70 years were selected for analysis in this 
study (n = 4 092). 
Risk-factor assessment for and definitions of cardiovascular 
disease 
Data were collected using a questionnaire administered by trained 
and standardised fieldworkers. An asset index – a measure of 
socioeconomic status – was derived from a composite score 
of a list of household items (electricity, television, telephone, 
refrigerator and washing machine) owned by the respondents. The 
respondent answered “yes” (code 1) or “no” (code 0) to each of 
the listed household items on the questionnaire. The scale derived 
was considered very reliable, as indicated by a very good internal 
consistency (Cronbach alpha score = 0.80). The scores were then 
ranked in order to classify the respondents into three socioeconomic 
categories.
The questionnaire also included questions on the respondents’ 
personal and family medical history, and their use of chronic 
medications. An interviewer inspected medication containers for listed 
drugs as part of the procedure for quality control of the data. Other 
information that was recorded, such as information on lifestyle and 
habits, included the respondents’ history of tobacco and/or alcohol 
use and a subjective estimation of the respondents’ discretionary salt 
intake. 
The fieldworkers assessed anthropometric measurements and blood 
pressure (BP) using methods previously detailed and published.17 
Hypertension was defined using the then South African hypertension 
guidelines (BP ≥ 160/95 mmHg and/or on antihypertensive 
medication). Risk estimation was done using this reference point, 
which was higher than the usual reference point of 140/90 mmHg, to 
allow our results to be comparable with related published literature, 
while also providing some understanding of policy implications for 
the findings locally. Hypercholesterolaemia was defined as reporting 
a past history of diagnosis of high cholesterol/fat or being on current 
medication for high blood cholesterol. Similarly, diabetes mellitus 
cases were defined as having a past history of diagnosis by a health 
professional of diabetes or high “blood sugar problem”.
Statistical analysis
Group differences were assessed using chi-square statistics and t-tests 
or ANOVA where the comparison included more than two groups. 
Statistical comparisons were made between categories of snuff use 
and known vascular disease risk factors and mean blood pressure 
readings. Multiple logistic regression models were constructed to 
determine an independent association of snuff use with hypertension, 
while adjusting for the influence of the covariates that have been 
identified in the literature and in our bivariate analysis as being 
significantly associated with hypertension and/or snuff use, i.e. the 
potential confounders. All statistical analyses were done using STATA 
software (Stata Corp 2003, Texas, USA), with appropriate weighting of 
and consideration for complex sample design. Odds ratios (OR) with 
a 95% confidence interval (CI) were used in estimating effect sizes. 
Statistical significance was set at 5%. 
Results
The prevalence of snuff use and hypertension was 14.6% and 18.0% 
respectively. On average, the snuff users were significantly older than 
non-users (49.2 years vs. 43.0 years; p<0.001). The use of snuff was 
more common among the poor and those in the middle socioeconomic 
class than among the richest (p<0.01). Higher education was inversely 
associated with snuff use; the prevalence decreasing from 21.6% 
among women who had no schooling to 2.5% among those who had 
more than 12 years of schooling (see Table I). Participants with higher 
education levels also tended not to have hypertension in a bivariate 
analysis, but this was not significantly associated with hypertension 
after controlling for potential confounders in a multiple regression 
analysis. 
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Table I:  Prevalence of snuff use and hypertension by socioeconomic and 
health/behavioural characteristics (weighted %)
Characteristics Snuff use (%) Hypertension (%)
Prevalence (95% CI) 14.6 (13.2–16.2) 18.0 (16.5–19.5)
Mean age (yrs) (SD) 49.2 yrs (13.0) 52.7 yrs (11.2)
Asset index (Tertiles) (N = 4078)
Poorest 16.2 15.7
Middle 15.8 17.7
Richest  9.1 22.2
P <0.01 P <0.001
Education level (N = 4078)
None 21.6 23.5
1–7 years schooling 15.7 19.9
8–12 years schooling 11.2 14.0
>12 years schooling  2.5   9.6
P <0.01 P <0.001
Lifestyle/habits
Ever Smoked (N = 4092)
No 15.6 17.6
Yes   1.1 21.8
P <0.01 P = 0.16




Body mass index (N = 3914)
Underweight (<18.5 kg/m2) 16.2 8.4
Normal (18.5–<25 kg/m2) 13.6 11.8
Overweight (≥25–30 kg/m2) 15.0 16.6
Obese (>30 kg/m2) 15.1 25.1
P = 0.74 P <0.001
Salt intake in food (N = 4088)
Not salted 20.8 16.5
Lightly salted 13.2 17.0
Very salty 28.3 37.8
P <0.01 P <0.001
Ever used alcohol (N = 4092)
No 12.4 17.5
Yes 27.4 20.7
P <0.01 P = 0.13
Compared to non-users, the mean systolic and diastolic blood 
pressure of snuff users were higher by at least 5 mmHg and 4 mmHg 
respectively (p < 0.001). A graded response was observed between 
the frequency of snuff use and mean systolic and diastolic BP (see 
Table II). Subsequent pair-wise post hoc contrast analysis (Bonferroni 
post-hoc test) showed that, compared to non-users, those who 
consumed snuff once to eight times and more daily had a significantly 
higher BP level than non-users (P <0.001). However, although those 
using snuff more than eight times a day had a higher BP than those 
consuming snuff less than eight times a day, the difference in BP was 
not statistically significant. The mean BP was also significantly raised 
among diabetics, but not significantly increased among respondents 
with hypercholesterolaemia. Hypertension was more prevalent among 
snuff users than among non-users – 23.9% vs. 17.0% [unadjusted 
odds ratio (OR) = 1.56; 95% confidence interval (CI): 1.20–2.02)].  
Nonetheless, in a multivariate analysis adjusting for family history of 
hypertension and the other significant risk factors for hypertension 
that are illustrated in Tables I and II, snuff use was not statistically 
significant (OR = 1.12; 95% CI: 0.84–1.50). 
Nonetheless, a dose response, albeit not statistically significant, was 
observed (see Table III). The median number of cigarettes smoked 
per day (CPD) was four. A statistically significant dose response was 
observed among current smokers, even after adjusting for potential 
confounders.
Table III: Multiple logistic regression model predicting hypertension (BP ≥160/95) 
Fully adjusted* 
OR (95% CI)
Current snuff use    
None 1
1–8 times daily 1.01 (0.75–1.36)
> 8 times daily 2.07 (0.89–4.82)
Body weight 
category
Normal (18.5–<25 kg/m2) 1
<18.5 kg/m2 0.57 (0.30–1.11)
25–30 kg/m2 1.44 (1.08–1.94)




Smokes 1–4 CPD 2.06 (0.98–4.34)
Smokes > 4 CPD 2.11 (1.06–4.20)
Extent of salt in 
food
Not salty 1
Lightly salty 0.98 (0.66–1.46)








*The final multivariate model, in addition to the variables displayed above, also 
controlled for age, smoking duration and Asset Index.
OR = odds ratio; CI = confidence interval.
Discussion
As far as could be ascertained, this study is the first to explore the 
association between hypertension and snuff use using a representative 
sample outside of developed countries. This study illustrates that 
Table II: Mean diastolic and systolic blood pressure by risk factors




Mean (SE) P value Mean (SE) P value
Snuff use status
Not current user 
(n = 3517) 121 (0.37) 77 (0.22)
Use 1–8 times/
day (n = 504) 126 (1.10) 81 (0.61)
> 8 times/day 
(n = 71) 131 (3.19) 84 (1.70)
P <0.001 P <0.001
Smoking history
Never smoked 
(n = 3725) 121 (0.48) 78 (0.26)
Quitted (n = 64) 123 (3.32) 79 (2.44)
Current smoker 
(n = 303) 125 (1.71) 80 (0.88)
P <0.01 P <0.01
Diabetes
No (n = 3923) 121 (0.36) 78 (0.21)
Yes (n = 145) 130 (2.22) 80 (1.04)
P <0.001 P = 0.04
Hypercholesterolaemia
No (n = 4031) 121 (0.36) 78 (0.21)
Yes (n = 18) 126 (7.49) 82 (3.94)
P = 0.43 P = 0.17
Study population 121 (0.35) 78 (0.21)
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snuff use is more prevalent among older women and those who are 
socio-economically disadvantaged. These women, who are often at 
a disadvantage in terms of access to quality health care, may thus be 
at greater risk for cardiovascular disease, given that snuff use was 
associated with an increase in BP. The observed increase in BP is 
consistent with findings from previous studies, which have suggested 
an increase in systolic and diastolic BP of the order of 10 to 20 
mmHg and 6 to 12 mmHg respectively.9 An increase in diastolic blood 
pressure of up to 5 mmHg has also been associated with increased 
risk for stroke, especially in normotensive populations.21,22 It is well 
established that a reduction in BP towards set goals, either through 
lifestyle modification or pharmacological interventions, reduces the risk 
for stroke, heart attacks and heart failure.23 Given that the findings of 
this study also suggest that snuff users are more likely to be those who 
tend to take in very salty foods, and that very salty food is associated 
in turn with a significantly increased risk for hypertension, interventions 
to prevent and control snuff use may therefore be critical in addressing 
cardiovascular risk among black South African women. 
Traditional risk factors, such as increased salt intake, obesity, smoking 
and family history, were confirmed to be associated with hypertension 
in this study. It is also pertinent to note that this study demonstrated 
a significantly increased risk of hypertension among current smokers 
with smoking intensities as low as just over four cigarettes per day, 
compared to those who had never smoked. However, in contrast to 
findings from previous studies,7,8 this study failed to show a significant 
independent association between the use of snuff and hypertension. 
The difference in this observation may be related to the differences 
in snuff products and additives used in the different countries and/or 
the differences in the socio-demographic characteristics of the study 
populations. The lack of statistical significance could also be explained 
by insufficient statistical power because of the small sample of heavy 
snuff users, as similarly noted in previous studies on the association 
between smokeless tobacco and cardiovascular disease.13,24 As 
previously noted by Rothman, it is a fallacy to infer a lack of association 
from a single P value, which in this case is a 95% CI that includes the 
figure 1.25 Nevertheless, consistent with some previous studies, the 
findings of this study support the view that constituents of tobacco 
smoke other than nicotine may be more strongly associated with the 
pathogenesis of hypertension.24,26 This is demonstrated by the fact 
that snuff, which has been reported to deliver as much nicotine as 
cigarettes,18 was not associated with a significant increase in the risk 
for hypertension, while cigarette smoking was – even at a relatively low 
intensity.
The major limitations of this study lie in the cross-sectional design 
and the reliance on self-reporting of tobacco use. This may result in 
reporting bias, especially with regard to smoking, which is considered 
a social taboo among black South Africans.27 Furthermore, information 
on the duration and the type of snuff used by respondents was not 
available in the 1998 SADHS data set. This may indeed be significant, 
as it was observed that smoking status was only significant after the 
lifetime duration of smoking was included in a multivariate model. In 
addition, those who had used snuff and quit were not categorised 
separately, thus they were inadvertently grouped with the reference 
group – “never/non-current snuff users” (misclassification bias). It is 
conceivable therefore that those who had only recently quit using 
snuff may still carry some residual risk during this “washout” period. 
Therefore, the non-significant association found in this study should be 
interpreted with caution. Despite these limitations, this study provided 
useful information on the association between snuff use and blood 
pressure in an under-studied population.
Conclusions
This study did not find a statistically significant association between 
snuff use and hypertension. While there is a need for controlled 
follow-up studies, the results of this study have both clinical and policy 
implications. These findings highlight the need for vigilance, especially 
as the frequent use of snuff was associated with a considerable 
increase in diastolic blood pressure in magnitudes that may be 
important for the risk of cardiovascular disease. The findings also 
highlight the need for primary care physicians to offer tobacco use 
cessation services to their patients, especially those who may already 
be exposed to other risk factors for hypertension.  
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